Literature DB >> 10924059

Matrix metalloproteinases and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivo.

L Lu1, Z Gunja-Smith, J F Woessner, P C Ursell, T Nissen, R E Galardy, Y Xu, P Zhu, G G Schwartz.   

Abstract

Severe ischemic injury or infarction of myocardium may cause activation of matrix metalloproteinases (MMPs) and damage the interstitial matrix. However, it is unknown whether MMP activation and matrix damage occur after moderate ischemia and reperfusion that result in myocardial stunning without infarction, and if so whether such changes contribute to postischemic myocardial expansion and contractile dysfunction. To address these questions, open-chest anesthetized pigs underwent 90 min of regional ischemia (subendocardial blood flow 0.4 +/- 0.1 ml. g(-1). min(-1)) and 90 min of reperfusion. After ischemia plus reperfusion, histological and ultrastructural examination revealed no myocardial infarction or inflammatory cell infiltration. Myocardial MMP-9 content increased threefold with a fourfold increase in the active form (P < 0.001). Myocardial collagenase content doubled (P < 0.01) but remained in latent form. MMP-2 and tissue inhibitors of metalloproteinases were unaffected. Despite increases in MMPs, collagen ultrastructure (assessed by cell maceration scanning electron microscopy) was unaltered. Intracoronary administration of the MMP inhibitor GM-2487 did not prevent or attenuate myocardial expansion (assessed by regional diastolic dimensions at near-zero left ventricular pressure) or contractile dysfunction. We conclude that although moderate ischemia and reperfusion alter myocardial MMP content and activity, these effects do not result in damage to interstitial collagen, nor do they contribute to myocardial expansion or contractile dysfunction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924059     DOI: 10.1152/ajpheart.2000.279.2.H601

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  15 in total

1.  A common mechanism for concurrent changes of diastolic muscle length and systolic function in intact hearts.

Authors:  L Lu; Y Xu; P Zhu; C Greyson; G G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-04       Impact factor: 4.733

Review 2.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

Review 3.  Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.

Authors:  Nikolaos G Frangogiannis; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

4.  Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction.

Authors:  Jiqiu Chen; Ching-Hsuan Tung; Jennifer R Allport; Si Chen; Ralph Weissleder; Paul L Huang
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

5.  Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.

Authors:  Saurabh Dahiya; Srikanth Givvimani; Shephali Bhatnagar; Natia Qipshidze; Suresh C Tyagi; Ashok Kumar
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

6.  Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies.

Authors:  E Herpel; S Singer; C Flechtenmacher; M Pritsch; F-U Sack; S Hagl; H A Katus; M Haass; H F Otto; P A Schnabel
Journal:  Virchows Arch       Date:  2005-04-02       Impact factor: 4.064

7.  Matrix metalloproteinase: investigation from gene to protein as effective factor in myocardial infarction.

Authors:  Sayyed Mohammad Hossein Ghaderian; Reza Akbarzadeh Najar; Akram Sadat Tabatabaei Panah; Gashin Rezaie; Azam Rezaei Farimani; Asghar Beigi Harchegani; Eznollah Azargashb
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

8.  Inhibition of matrix metalloproteinase activity prevents increases in myocardial tumor necrosis factor-alpha.

Authors:  David B Murray; Scott P Levick; Gregory L Brower; Joseph S Janicki
Journal:  J Mol Cell Cardiol       Date:  2010-04-18       Impact factor: 5.000

Review 9.  The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

Review 10.  Effects of brief ischemia and reperfusion on the myocardium and the role of nitric oxide.

Authors:  Christopher S R Baker; Sanjay Kumar; Ornella E Rimoldi
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.